Trademark Overview
On Thursday, June 6, 2024, a trademark application was filed for ACCUTRIC with the United States Patent and Trademark Office. The USPTO has given the ACCUTRIC trademark a serial number of 98589564. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 7, 2024. This trademark is owned by DEFENCE THERAPEUTICS INC.. The ACCUTRIC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Radiopharmaceutical drug delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical theranostic delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical imaging delivery agent in the form of an intracellular and nuclear enhancer; medicinal preparations for use in oncology; pharmaceutical radio-immuno-conjugate (radiolabeled antibody) preparations for the treatment, diagnosis and theranosis of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical radiolabeled antibodies for the treatment, diagnosis and theranosis of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and fo...
Antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of immunotherapy; scientific research for medical purposes in the field of oncology
